Additionally, we identified a significant association of genes involved in treatment response in breast cancer with genes producing splicing-derived neoepitopes (ERBB2, ESR1, TIMP1, ABCC3) or potentially depleted self-epitopes (AKT1, CCNE1, RET, TFF3). This evidence concerns the gene TIMP1 and breast carcinoma.